- Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM (2006) Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. AIDS 20:2123–2125.
- Cavrois M, Neidleman J, Kreisberg JF, Fenard D, Callebaut C, Greene WC (2006) Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 80:1992–1999.
- Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valente AJ (2006) Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J. Biol. Chem. 281:15099–15109.
- Chiu Y-L, Greene WC (2006) APOBEC3 cytidine deaminases: Distinct antiviral actions along the retroviral life cycle. J. Biol. Chem. 281:8309–8312.
- Chiu Y-L, Greene WC (2006) Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol. 27:291–297.
- Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, Heidmann T, Greene WC (2006) High-molecular mass APOBEC3G complexes restrict Alu retrotransposition. PNAS 103:15588–15593.
- Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM (2006) Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: Evidence ffor a constraint on the ability of HIV to completely evade neutralizing antibody responses. J. Virol. 80:6155–6164.
- Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, Greenblatt R (2006) Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. J. Acquir. Immune Defic. Syndr. 41:68–74.
- Grant RM. Antiretroviral treatment in recently infected persons. In: Yu V (Ed.), Approach Towards Management of HIV Infection and Its Related Complications Lippincott, Williams and Wilkins, Hagerstown, MD. In Press.
- Grant RM, Wainberg MA (2006) Chemoprophylaxis of HIV infection: moving forward with caution. J. Infect. Dis. 194:874–876.
- Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM (2006) Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clin. Infect. Dis. 42:700–708.
- Jordan KA, Furlan SN, Gonzalez VD, Karlsson AC, Quigley MF, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK (2006) CD8 T cell effector maturation in HIV-1 infected children. Virology 347:117–126.
- Kasler H, Verdin E. The class IIa histone deacetylases: Functions and regulation. In: Verdin E (Ed.),Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions Humana, Totowa, New Jersey, 2006, pp. 129–164.
- Kreisberg JF, Yonemoto W, Greene WC (2006) Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high-molecular-mass APOBEC3G complex formation. J. Exp. Med. 203:865–870.
- Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, Whittington WL, Celum C, Grant RM (2006) Linking HIV and antiretroviral drug resistance surveillance in Peru: A model for a third-generation HIV sentinel surveillance. J. Acquir. Immune Defic. Syndr. 42:501–505.
- Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, Diaz RS, Santos AM, Succi RC, Abadi J, Rosenberg MG, de Moraes-Pinto MI, Kallas EG (2006) Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 1:e102.
- Levy V, Grant RM (2006) Antiretroviral therapy for hepatitis B virus-HIV–coinfected patients: promises and pitfalls. Clin. Infect. Dis. 43:904–910. Erratum in: Clin. Infect. Dis. 43:1376.
- Liu AY, Grant RM, Buchbinder SP (2006) Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA 296:863–865.
- Mahmoudi T, Parra M, Vries RG, Kauder SE, Verrijzer CP, Ott M, Verdin E (2006) The SW1/SNF chromatin-remodeling complex is a cofactor for tat transactivation of the HIV promoter. J. Biol. Chem. 281:19960–19968.
- Michaelsson J, Mold JE, McCune JM, Nixon DF (2006) Regulation of T cell responses in the developing human fetus. J. Immunol. 176:5741–5748.
- Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF (2006) Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 107:3081–3083.
- Nieters A, Kallinowski B, Brennan P, Ott M, Maynadie M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, Becker N, de Sanjose S (2006) Hepatitis C and risk of lymphoma: Results of the European multi-center case-control study EPILYMPH. Gastroenterology 131:1879–1896.
- Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN, McCune JM, Nixon DF, Maecker HT (2006) IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. AIDS Res. Ther. 3:18.
- O’Mahony A, Raber J, Foehr E, Montano M, Han V, Lu S, Kwon H, LeFevour A, Chakraborty-Sett S, Greene WC (2006) NF-kB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity. Mol. Cell Biol. 26:7283–7298.
- Papasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes Am, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ (2006) HIV-1 specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. J. Clin. Immunol. 26:40–54.
- Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, Sheehy ME, Ortiz GM, Ogg GS, Barbour JD, Lenz J, Steinfeld AD, Nixon DF (2006) Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res. Hum. Retroviruses 22:52–56.
- Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, Maltepe E, Okazaki K, Kochman R, Vo KC, Guidice L, Erlebacher A, McCune JM, Stoddart CA, Fisher SJ (2006) An in vivo model of human placentation reveals cytotrophoblast induction of arterial apoptosis and lymphangiogenesis. J. Clin. Invest. 116:2643–2652.
- Sanchez MS, Grant RM, Porco TC, Getz WM (2006) HIV drug-resistant strains as epidemiological sentinels. Emerg. Infect. Dis. 12:191–197.
- Saunders LR, Verdin E (2006) Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. Mol. Cancer Ther. 5:2777–2785.
- Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. USA 103:10224–10229.
- Soros VB, Greene WC (2006) APOBEC3G and HIV-1: Strike and counterstrike. Curr. Inf. Dis. Rep. 8:317–323.
- Stoddart CA, Reyes RA (2006) Models of HIV-1 disease: A review of current status. Drug Discov. Today: Disease models 3:113–119.
- Trapp J, Jochum A, Meier R, Saunders L, Marshall B, Kunick C, Verdin E, Goekjian P, Sippl W, Jung M. (2006) Adenosine mimetics as inhibitors of NAD(+)-dependent histone deacetylases, from
kinase to sirtuin inhibition. J. Med. Chem. 49:7307–7316.
- Truong HH, Grant RM, McFarland W, Kellogg T, Kent C, Louie B, Wong E, Klausner JD (2006) Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS 20:2193–2197.
- Truong HH, Kellogg T, Klausner JD, Katz MH, Dilley J, Knapper K, Chen S, Prabhu R, Grant RM, Louie B, McFarland W (2006) Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex. Transm. Infect. 82:461–466.
- Williams SA, Chen L-f, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC (2006) NF-kB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139–149.
- Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, Mundt P, Williams SA, Warmerdam M, Kahn J, Hecht FM, Grant RM, de Noronha CMC, Weyrich AS, Greene WC, Planelles V (2006) HIV-1 Vpr induces DNA replication stress in vitro and in vivo. J. Virol. 80:10407–10418.
|
